β-Blockers in Chronic Heart Failure
Top Cited Papers
- 1 April 2003
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 107 (12), 1570-1575
- https://doi.org/10.1161/01.cir.0000065187.80707.18
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Lifetime Risk for Developing Congestive Heart FailureCirculation, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureThe New England Journal of Medicine, 2001
- HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approachesJournal of Cardiac Failure, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivityJournal of Hypertension, 1996
- Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockadeJournal of the American College of Cardiology, 1995
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975